Molecular and functional characterization of V(1b) vasopressin receptor in rat adrenal medulla

Endocrinology

Volumn 137, Issue 9, 1996, Pages 3906-3914

  Grazzini, Eric ^a   Lodboerer, Anne Marie ^a   Perez Martin, Antonia ^a   Joubert, Dominique ^a   Guillon, Gilles ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; COMPLEMENTARY DNA; GENE PRODUCT; RECEPTOR SUBTYPE; RELCOVAPTAN; VASOPRESSIN; VASOPRESSIN ANTAGONIST; VASOPRESSIN V1 RECEPTOR;

ADRENAL MEDULLA; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM MOBILIZATION; CARDIOVASCULAR EFFECT; CATECHOLAMINE SYNTHESIS; CONTROLLED STUDY; FEMALE; FLUID BALANCE; HYPOTHALAMUS HYPOPHYSIS SYSTEM; LEARNING; MEMORY; MESSENGER RNA SYNTHESIS; MOLECULAR CLONING; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; THERMOREGULATION; ZONA GLOMERULOSA;

EID: 0029813765     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.137.9.8756565     Document Type: Article

References (50)

1. Butlen D, Guillon G, Rajerison RM, Jard S 1978 Structural requirements for activation of vasopressin-sensitive adenylate cyclase, hormone binding, and antidiuretic actions: effects of highly potent analogues and competitive inhibitors. Mol Pharmacol 14:1006-1017
2. Jard S, Butlen D, Cantau B, Guillon G, Marie J, Roy C 1984 The Mechanisms of Action of Antidiuretic Hormone. Year Book Medical, New York, pp 163-177
3. Jard S, Elands J, Schmidt A, Barberis C 1988 Vasopressin and oxytocin receptors: an overview. Prog Enclocrinol 2:1183-1188
4. Gillies GE, Linton EA, Lowry PJ 1982 Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin. Nature 299:355-357
5. Guillon G 1989 Les récepteurs à la vasopressine, l'ocytocine et l'angiotensine chez les mammiféres. Ann Endocrinol (Paris) 50:425-433
6. Berecek KH, Swords BH 1990 Central role for vasopressin in cardiovascular regulation and the pathogenesis of hypertension. Hypertension 16:213-224
7. Barberis C, Audigier S, Durroux T, Elands J, Schmidt A, Jard S 1992 Pharmacology of oxytocin and vasopressin receptors in the central and peripheral nervous system. Ann NY Acad Sci 652:39-45
8. De Wied D 1971 Long-term effect of vasopressin on the maintenance of a conditioned avoidance response in rats. Nature 232:58-60
9. 2 receptor and possible link to nephrogenic diabetes insipidus. Nature 357:336-339
10. Guillon G, Balestre MN, Mouillac B, Devilliers G 1986 Activation of membrane phospholipase C by vasopressin. FEBS Lett 196:155-159
11. Gallo-Payet N, Chouinard L, Balestre MN, Guillon G 1991 Involvement of protein kinase C in the coupling between the V1 vasopressin receptor and phospholipase C in rat glomerulosa cells: effects on aldosterone secretion. Endocrinology 129:623-634
12. Schmidt A, Audigier S, Barberis C, Jard S, Manning M, Kolodziejczyk AS, Sawyer WH 1991 A radioiodinated linear vasopressin antagonist: a ligand with high affinity and specificity for V1a receptors. FEBS Lett 282:77-81
13. 1a receptors. J Clin Invest 92:224-231
14. Jard S, Gaillard RC, Guillon G, Marie J, Schoenenberg P, Muller AF, Manning M, Sawyer WH 1986 Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis. Mol Pharmacol 30:171-177
15. 1b vasopressin receptor gene. Proc Natl Acad Sci USA 92:6783-6787
16. 1a arginine vasopressin receptor. Nature 356:523-526
17. Thibonnier M, Auzan C, Madhun Z, Wilkins P, Bertimattera L, Clauser E 1994 Molecular cloning, sequencing, and functional expression of a cDNA encoding the human V(1a) vasopressin receptor. J Biol Chem 269:3304-3310
18. 1b vasopressin receptor. J Biol Chem 269:27088-27099
19. Birnbaumer M, Seibold A, Gilbert S, Ishido M, Barberis C, Antaramian A, Brabet P, Rosenthal W 1992 Molecular cloning of the receptor for antidiuretic hormone. Nature 357:333-335
20. Guillon G, Trueba M, Joubert D, Grazzini E, Chouinard L, Coté M, Payet MD, Manzoni O, Barberis C, Robert M, Gallo-Payet N 1995 Vasopressin stimulates steroid secretion in human adrenal glands: comparison with angiotensin II effect. Endocrinology 136:1285-1295
21. Guillon G, Gallo-Payet N 1986 Specific vasopressin binding to rat adrenal glomerulosa cells. Relationship to inositol lipid breakdown. Biochem J 235:209-214
22. Nussey SS, Ang VTY, Jenkins JS, Chowdrey HS, Bisset GW 1984 Brattleboro rat contains vasopressin. Nature 310:64-66
23. Antoni FA 1984 Characterization of high affinity binding sites for vasopressin in bovine adrenal medulla. Neuropeptides 4:413-420
24. Bird IM 1990 Agonist-stimulated turnover of the phosphoinositides and the regulation of adrenocortical steroidogenesis. J Mol Endocrinol 5:191-209
25. Roussel JP, Grazzini E, Zumbihl R, Rodriguez E, Astier H 1995 Triiodo-L-thyronine enhances TRH-induced TSH release from perifused rat pituitaries and intracellular calcium levels from dispersed pituitary cells. Eur J Pharmacol 289: 205-215
26. Zimlichman R, Goldstein DS, Zimlichman S, Stull R, Keiser HR 1987 Angiotensin II increases cytosolic calcium and stimulates catecholamine release cultured bovine adrenomedullary cells. Cell Calcium 8:315-325
27. Prévostel C, Alvaro V, De Boisvilliers F, Martin A, Jaffiol C, Joubert D 1995 The natural protein kinase Ca mutant is present in human thyroid neoplasms. Oncogene 11:669-674
28. Schwartz J, Derdowska I, Sobocinska M, Kupryszenwski G 1991 A potent new synthetic analog of vasopressin with relative agonist specificity for the pituitary. Endocrinology 129:1107-1109
29. Ivell R, Richter D 1984 Structure and comparison of the oxytocin and vasopressin genes from rat. Proc Natl Acad Sci USA 81:2006-2010
30. Vandesande F, Dierickx K 1975 Identification of the vasopressin producing and oxytocin producing neurons in the hypothalamus magnocellular neurosecretory system of the rat. Cell Tissue Res 164:153-162
31. Aguilera G, Pham QC, Rabadandiehl C 1994 Regulation of pituitary vasopressin receptors during chronic stress: Relationship to corticotroph responsiveness. J Neuroendocrinol 6:299-304
32. 2+ in rat medullary collecting tubules. Am J Physiol 265:F35-F45
33. Phillips P A, Abrahams JM, Kelly JM, Mooser V, Trinder D, Johnston CI 1990 Localization of vasopressin binding sites in rat tissues using specific V1 and V2 selective ligands. Endocrinology 126:1478-1484
34. 1a receptors. J Clin Endocrinol Metab 76:1522-1527
35. Yon L, Feuilloley M, Chartrel N, Arimura A, Foumier A, Vaudry H 1993 Localization, characterization and activity of pituitary adenylate cyclase-activating polypeptide (PACAP) in the frog adrenal gland. J Endocrinol 139:183-194
36. Gallo-Payet N 1993 Nouveaux concepts sur la régulation de la sécrétion d'aldostérone; interactions endocrines, paracrines, autocrines et neurocrines. Med Sci 9:943-951
37. Markowska A, Rebuffat P, Rocco S, Gottardo G, Mazzocchi G, Nussdorfer G 1993 Evidence that an extra hypothalamic pituitary corticotropin-releasing hormone (CRH)/adrenocorticotropin (ACTU) system controls adrenal growth and secretion in rats. Cell Tissue Res 272:439-445
38. Mazzocchi G, Malendowicz LK, Markowska A, Nussdorfer GG 1994 Effect of hypophysectomy on corticotropin-releasing hormone and adrenocorticotropin immunoreactivities in the rat adrenal gland. Mol Cell Neurosci 5:345-349
39. Jones CT, Edwards AV 1990 Release of adrenocorticotrophin from the adrenal gland in the conscious calf. J Physiol 426:397-407
40. Liu JQ, Heikkila P, Voutilainen R, Karonen SL, Kahri AI 1994 Pheochromocytoma expressing adrenocorticotropin and corticotropin-releasing hormone; regulation by glucocorticoids and nerve growth factor. Eur J Endocrinology 131:221-228
41. O'Brien T, Young WF, Davila DG, Scheithauer BW, Kovacs K, Horvath E, Vale W, Van Heerden JA 1992 Cushing's syndrome associated with ectopic production of corticotrophin-releasing hormone, corticotrophin and vasopressin by a pheochromocytoma. Clin Endocrinol 37:460-467
42. Porter ID, Whitehouse BJ, Taylor AH, Nussey SS 1988 Effect of arginine vasopressin and oxytocin on acetylcholine-stimulation of corticosteroid and catecholamine secretion from rat adrenal gland perfused in situ. Neuropeptides 12:265-271
43. Vitris M, Biouele JM, Binam F, Simeu C, Demaziere J, Saissy JM, Aubert M 1991 Failure of medical treatment with antihypertensive agents in child with pheochromocytoma. Recovery after surgery. Cah Anesthesiol 39:188-190
44. Colleen RL, Bauce L, Veale WL, Pittman QJ 1986 The effects of intrathecal administration of arginine-vasopressin and substance P on blood pressure and adrenal secretion of epinephrine in rats. J Auton Nerv Syst 16:91-99
45. Andreis PG, Neri G, Mazzocchi G, Musajo F, Nussdorfer G 1992 Direct secretagogue effect of corticotropin-realising hormone factor on the rat adrenal cortex: the involvement of the zona medullaris. Endocrinology 131:69-77
46. Gallo-Payet N, Pothier P, Isler H 1987 On the presence of chromaffin cells in the adrenal cortex: their possible role in adrenocortical function. Biochem Cell Biol 65:588-592
47. Lacroix A 1995 Rôle des anomalies des récepteurs hormonaux dans la physiopathologie des tumeurs corticosurrénaliennes. Ann Endocrinol (Paris)56:614-615
48. Lefebvre DL, Giaid A, Bennett H, Larrivière R, Zingg HH 1992 Oxytocin gene expression in rat uterus. Science 256:1553-1555
49. Lefebvre D, Zingg HH 1991 Novel vasopressin transcripts in rat testis. Mol Endocrinol 5:645-652
50. Foo NC, Funkhouser JM, Carter DA, Murphy D 1994 A testis-specific promoter in the rat vasopressin gene. J Biol Chem 269:659-667